Many investigations have already reported that the pathophysiology of myocardial injury in COVID‐19 patients may be linked to dysregulation of immune response, presenting with lower lymphocyte counts, higher leukocytes counts, and significantly reduced CD4+ and CD8+ T lymphocytes levels.23, 24, 25. This evidence concerns the gene CD4 and COVID-19.